NeuShen Therapeutics Closes Pre-A Financing with ~$20M
/PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders...
Source: prnewswire.com
📰 Yahong Meditech News
Yahong Meditech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Yahong Meditech. Real-time updates on events, politics, business and more.
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule...
Source: prnewswire.com